通过风险分层来个人预防与质子抑制剂相关的不良事件
Bin Xia1,2, Qiangsheng He1,2, Fang Gao Smith3,4
1Department of Epidemiology and Biostatistics, Clinical Big Data Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
质子抑制剂 (PPI) 与15种主要疾病的更高风险有关. 以风险分层为指导的个性化PPI使用可能会改善患者的安全性和决策.
科学领域:
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 质子抑制剂 (PPI) 广泛用于与酸有关的胃肠道疾病.
- 需要进一步阐明PPI与主要全球疾病的全面安全概况和风险关联.
研究的目的:
- 调查PPI使用与患15种全球主要疾病的风险之间的关联.
- 探索与PPI相关的疾病负担的剂量-反应关系和风险分层.
主要方法:
- 分析了来自美国,英国和中国的五个潜在队伍的200多万参与者.
- 统计检查PPI使用与15种主要疾病发生率之间的相关性,包括剂量反应和风险分层.
主要成果:
- 使用PPI与15种全球主要疾病的风险增加有关,包括缺血性心脏病,糖尿病,呼吸道感染和慢性病.
- 在不同类型的PPI中观察到一致的剂量反应关系.
- 与PPI相关的绝对风险在基线疾病风险较高的人群中较高.
结论:
- 该研究强调了与PPI使用相关的潜在安全问题,证明了与许多主要疾病的联系.
- 风险分层可能对个性化PPI处方至关重要,优化患者和临床医生的决策.
- 虽然已注意到相关性,但需要进一步的研究来确认因果关系并完善临床指南.
更多相关视频
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
